335 related articles for article (PubMed ID: 29753164)
1. A novel approach of virulome based reverse vaccinology for exploring and validating peptide-based vaccine candidates against the most troublesome nosocomial pathogen: Acinetobacter baumannii.
Ahmad S; Azam SS
J Mol Graph Model; 2018 Aug; 83():1-11. PubMed ID: 29753164
[TBL] [Abstract][Full Text] [Related]
2. Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets.
Hassan A; Naz A; Obaid A; Paracha RZ; Naz K; Awan FM; Muhmmad SA; Janjua HA; Ahmad J; Ali A
BMC Genomics; 2016 Sep; 17(1):732. PubMed ID: 27634541
[TBL] [Abstract][Full Text] [Related]
3. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii.
Solanki V; Tiwari V
Sci Rep; 2018 Jun; 8(1):9044. PubMed ID: 29899345
[TBL] [Abstract][Full Text] [Related]
4. Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery.
Ahmad S; Ranaghan KE; Azam SS
Eur J Pharm Sci; 2019 Apr; 132():1-17. PubMed ID: 30797936
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.
Ni Z; Chen Y; Ong E; He Y
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230771
[TBL] [Abstract][Full Text] [Related]
6. New putative vaccine candidates against Acinetobacter baumannii using the reverse vaccinology method.
Fereshteh S; Abdoli S; Shahcheraghi F; Ajdary S; Nazari M; Badmasti F
Microb Pathog; 2020 Jun; 143():104114. PubMed ID: 32145321
[TBL] [Abstract][Full Text] [Related]
7. Reverse Vaccinology Approach to Potential Vaccine Candidates Against Acinetobacter baumannii.
Shahid F; Ashraf ST; Ali A
Methods Mol Biol; 2019; 1946():329-336. PubMed ID: 30798567
[TBL] [Abstract][Full Text] [Related]
8. Chimeric vaccine designs against Acinetobacter baumannii using pan genome and reverse vaccinology approaches.
Shahid F; Zaheer T; Ashraf ST; Shehroz M; Anwer F; Naz A; Ali A
Sci Rep; 2021 Jun; 11(1):13213. PubMed ID: 34168196
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical and structural characterization, epitope mapping and vaccine potential investigation of a new protein containing Tetratrico Peptide Repeats of Acinetobacter baumannii: An in-silico and in-vivo approach.
Abdollahi S; Raoufi Z; Fakoor MH
Mol Immunol; 2021 Dec; 140():22-34. PubMed ID: 34649027
[TBL] [Abstract][Full Text] [Related]
10. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
Garg N; Singh R; Shukla G; Capalash N; Sharma P
Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
[TBL] [Abstract][Full Text] [Related]
11. In Silico Design and Evaluation of Acinetobacter baumannii Outer Membrane Protein a Antigenic Peptides As Vaccine Candidate in Immunized Mice.
Mehdinejadiani K; Bandehpour M; Hashemi A; Ranjbar MM; Taheri S; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):655-663. PubMed ID: 32245309
[TBL] [Abstract][Full Text] [Related]
12. In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of Outer membrane protein A.
Jahangiri A; Rasooli I; Owlia P; Fooladi AA; Salimian J
Microb Pathog; 2017 Apr; 105():201-210. PubMed ID: 28242426
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
[TBL] [Abstract][Full Text] [Related]
14. Putative novel B-cell vaccine candidates identified by reverse vaccinology and genomics approaches to control Acinetobacter baumannii serotypes.
Beiranvand S; Doosti A; Mirzaei SA
Infect Genet Evol; 2021 Dec; 96():105138. PubMed ID: 34793968
[TBL] [Abstract][Full Text] [Related]
15. Identification of Antigenic Properties of Acinetobacter baumannii Proteins as Novel Putative Vaccine Candidates Using Reverse Vaccinology Approach.
Piri-Gharaghie T; Doosti A; Mirzaei SA
Appl Biochem Biotechnol; 2022 Oct; 194(10):4892-4914. PubMed ID: 35670904
[TBL] [Abstract][Full Text] [Related]
16. Towards a peptide-based vaccine against Shigella sonnei: A subtractive reverse vaccinology based approach.
Baseer S; Ahmad S; Ranaghan KE; Azam SS
Biologicals; 2017 Nov; 50():87-99. PubMed ID: 28826780
[TBL] [Abstract][Full Text] [Related]
17. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
[TBL] [Abstract][Full Text] [Related]
18. Immuno-informatics driven proteome-wide investigation revealed novel peptide-based vaccine targets against emerging multiple drug resistant Providencia stuartii.
Asad Y; Ahmad S; Rungrotmongkol T; Ranaghan KE; Azam SS
J Mol Graph Model; 2018 Mar; 80():238-250. PubMed ID: 29414043
[TBL] [Abstract][Full Text] [Related]
19. Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant
Mujawar S; Mishra R; Pawar S; Gatherer D; Lahiri C
Front Cell Infect Microbiol; 2019; 9():203. PubMed ID: 31281799
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii.
Moriel DG; Beatson SA; Wurpel DJ; Lipman J; Nimmo GR; Paterson DL; Schembri MA
PLoS One; 2013; 8(10):e77631. PubMed ID: 24116234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
